Canadian University initiated COVID-19 Emergency Department Registry
The University of British Columbia is commencing recruitment for the clinical trial of the Canadian COVID-19 Emergency Department Registry.
The condition is Covid-19.
Coronavirus Disease 2019 (COVID -19) is the largest public health crisis in over a century. There is an urgent need for high-quality population-level data to understand modifiable risks for disease severity, transmissibility, and to develop evidence-based prevention (i.e. vaccination), treatment and resource allocation strategies.
The Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) created a population-based registry of suspected and confirmed consecutive cases of COVID-19. The purpose of this registry is to derive and validate clinical decision rules, evaluate diagnostic tests and vaccine effectiveness, and complete cohort, case-control and observational studies to inform the pandemic response.
This national multi-centre registry is designed to enroll population-based consecutive eligible patients presenting with suspected or confirmed COVID-19 to 50 emergency departments in eight Canadian provinces from March 1 2020 and data collection is ongoing for the duration of the pandemic.
Data will be abstracted from the medical chart and entered into a central, web-based REDCap database. The investigators adopted the ISARIC variables into the database where there was a match. The investigators will develop standardized operating procedures for screening of potentially eligible patients, data entry and follow-up.
The Health Data Research Network facilitated the development of a unique data flow of personal health identifiers and study identification numbers from each province for all participating institutes. This will allow linkage of registry data with national administrative data repositories.
A clinical trial is recruiting patients in the following locations: Canada.
The trial officially began on the March 1, 2020 and is planned to complete on December 31, 2023.
Patients presenting to participating Canadian emergency departments with suspected and or confirmed COVID-19 can be enrolled into this study.
The investigators defined two periods for enrollment based on the availability of COVID-19 testing. Research assistants used medical microbiology testing and discharge diagnoses to screen for potentially eligible patients.
In Period 1, COVID-19 testing in each province was restricted to specific patient populations (e.g., healthcare workers, admitted patients).
Period 2 started on the date which each province expanded testing criteria allowing clinicians to test patients based on clinical suspicion or policy.
Genome British Columbia, Canadian Institutes of Health Research (CIHR) and Canadian Critical Care Trials Group are the collaborators in this clinical trial.
The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT04702945
